Is symptom duration before DMARD therapy a determinant of direct and indirect costs in DMARD-naïve RA patients?

Ilfita Sahbudin^*, Ruchir Singh, Jen Trickey, Aliaksandra Baranskaya, Alexander Tracy, Karim Raza, Andrew Filer, Sue Jowett, Annelies Boonen

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

13 Downloads (Pure)

1 Finished
1 Active

2 results

Active
Rheumatoid Arthritis Centre for Excellence (RACE 2)
Filer, A., Lord, J., Raza, K., Scheel-Toellner, D., Anderson, G., Buckley, C., Clark, A. & Falahee, M.
ARTHRITIS RESEARCH UK
1/04/19 → 30/09/25
Project: Research
Finished
FP7 COLLAB - EUROTEAM- Towards Early Diagnosis and Biomarker Validation in Arthritis Management
Buckley, C. & Raza, K.
European Commission - Management Costs, European Commission
1/11/12 → 31/10/16
Project: Research